Artículos por temáticas

Apathy as a behavioural marker of cognitive impairment in Parkinson's disease: a longitudinal analysis

Martin GP, McDonald KR, Allsop D, Diggle PJ, Leroi I.

J Neurol. 2020 Jan;267(1):214-227. doi: 10.1007/s00415-019-09538-z. Epub 2019 Oct 15.

Using induced pluripotent stem cells for modeling Parkinson's disease.

Ke M, Chong CM, Su H.

World J Stem Cells. 2019 Sep 26;11(9):634-649. doi: 10.4252/wjsc.v11.i9.634. Review.

Iron Concentration Does Not Differ in Blood but Tends to Decrease in Cerebrospinal Fluid in Parkinson's Disease.

Shen X, Yang H, Zhang D, Jiang H.

Front Neurosci. 2019 Sep 26;13:939. doi: 10.3389/fnins.2019.00939. eCollection 2019.

Subjective estimates of uncertainty during gambling and impulsivity after subthalamic deep brain stimulation for Parkinson's disease.

Paliwal S, Mosley PE, Breakspear M, Coyne T, Silburn P, Aponte E, Mathys C, Stephan KE.

Sci Rep. 2019 Oct 15;9(1):14795. doi: 10.1038/s41598-019-51164-2.

A novel summary kinematic index for postural characterization in subjects with Parkinson's disease

Arippa F, Pau M, Cimolin V, Stocchi F, Goffredo M, Franceschini M, Condoluci C, De Pandis MF, Galli M.

Eur J Phys Rehabil Med. 2020 Apr;56(2):142-147. doi: 10.23736/S1973-9087.19.05803-9. Epub 2019 Oct 15.

Novel application of the gray-level co-occurrence matrix analysis in the parvalbumin stained hippocampal gyrus dentatus in distinct rat models of Parkinson's disease.

Rajkovic N, Ciric J, Milosevic N, Saponjic J.

Comput Biol Med. 2019 Oct 4;115:103482. doi: 10.1016/j.compbiomed.2019.103482. [Epub ahead of print]

Novel POLG mutation in a patient with early-onset parkinsonism, progressive external ophthalmoplegia and optic atrophy

Ma L, Mao W, Xu E, Cai Y, Wang C, Chhetri JK, Chan P.

Int J Neurosci. 2020 Apr;130(4):319-321. doi: 10.1080/00207454.2019.1681422. Epub 2019 Nov 7.

Signal Alteration of Substantia Nigra on 3.0T Susceptibility-weighted Imaging in Parkinson's Disease and Vascular Parkinsonism.

Zhao XJ, Niu XY, You HY, Zhou M, Ji XB, Liu Y, Wu L, Ding XL.

Curr Med Sci. 2019 Oct;39(5):831-835. doi: 10.1007/s11596-019-2113-4. Epub 2019 Oct 14.

Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson's Disease.

Mulak A, Koszewicz M, Panek-Jeziorna M, Koziorowska-Gawron E, Budrewicz S.

Front Neurosci. 2019 Sep 27;13:992. doi: 10.3389/fnins.2019.00992. eCollection 2019.

Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.

[No authors listed]

Neurology. 2019 Oct 15;93(16):725. doi: 10.1212/WNL.0000000000008490. No abstract available.

Faecal Transplantation, Pro- and Prebiotics in Parkinson's Disease; Hope or Hype?

Van Laar T, Boertien JM, Herranz AH.

J Parkinsons Dis. 2019 Oct 8. doi: 10.3233/JPD-191802. [Epub ahead of print]

Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson's Disease.

van Kessel SP, El Aidy S.

J Parkinsons Dis. 2019 Oct 9. doi: 10.3233/JPD-191780. [Epub ahead of print]

Delayed Clinical Manifestation of Parkinson's Disease Among Physically Active: Do Participants in a Long-Distance Ski Race Have a Motor Reserve?

Olsson TT, Svensson M, Hållmarker U, James S, Deierborg T.

J Parkinsons Dis. 2020;10(1):267-274. doi: 10.3233/JPD-191762.

Inflammatory Bowel Diseases and Parkinson's Disease.

Brudek T.

J Parkinsons Dis. 2019 Oct 8. doi: 10.3233/JPD-191729. [Epub ahead of print]

The Effects of Computer-Based Cognitive Rehabilitation on Working Memory in Patients with Parkinson's Disease: A Systematic Review

Svaerke K, Niemeijer M, Løkkegaard A.

J Parkinsons Dis. 2020;10(1):47-57. doi: 10.3233/JPD-191726.